TrialJournal of Crohn's & colitis2024

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis.

Subrata Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.